Delivery Order SPE2DR25D1104-SPE2DR26FK236
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ketorolac 15 mg/ml vials at a firm fixed price ceiling value of $1,476.08. This is an unset-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,339.14. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The order is scheduled for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,163.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials on November 3, 2025, with completion scheduled for November 4, 2025. This contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of Ketorolac 60mg/2ml in quantities of 25 units. This firm fixed-price delivery order, valued at $8,163.57, represents a non-competitive award and is scheduled for completion by December 2, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility and supports the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vial supply, with a ceiling value of $5,818.80. This competitive award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 7, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a non-set-aside award, this contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 mg/mL ketorolac vials valued at $5,184.25 on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK236Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,126.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that serves as the primary global pharmaceutical supply mechanism for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies a broad portfolio of medications and medical supplies to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract history with DLA demonstrates consistent performance in delivering both brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Ketorolac delivery—a nonsteroidal anti-inflammatory pain management medication—reflects the company's ongoing role in supporting military medical supply chain requirements through the DLA Troop Support Medical prime vendor contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/5/25 |